Personal information

Activities

Employment (1)

Mossakowski Medical Research Institute: Warsaw, PL

(Department of Neurotoxicology)
Employment
Source: Self-asserted source
Monika Szeliga

Funding (4)

Role of GAB glutaminase in glioblastoma.

2022-01 to 2025-12 | Grant
National Science Centre Poland (Cracow, PL)
Source: Self-asserted source
Monika Szeliga

Peroxiredoxins as potential therapeutic targets in glioblastoma.

2018-01 to 2023-01 | Grant
National Science Centre (Cracow, PL)
GRANT_NUMBER:

2017/25/B/NZ7/00388

Source: Self-asserted source
Monika Szeliga

New 1,3,4-thiadiazole derivatives as inhibitors of critical steps of the glutamine-glutamate cycle in glioblastoma cells.

2014 to 2017 | Grant
National Science Centre (Cracow, PL)
GRANT_NUMBER:

2013/11/D/NZ7/00925

Source: Self-asserted source
Monika Szeliga

The influence of the modulation of glutaminase expression on the phenotype of glioblastoma cells and their sensitivity to alkylating agents.

2010 to 2013 | Grant
Ministry of Science and Higher Education (Warsaw, PL)
GRANT_NUMBER:

No N N401 039238

Source: Self-asserted source
Monika Szeliga

Peer review (16 reviews for 8 publications/grants)

Review activity for Biomedicines. (1)
Review activity for Cellular and molecular neurobiology. (2)
Review activity for Diseases (1)
Review activity for Journal of biomedical science (1)
Review activity for Journal of clinical medicine. (1)
Review activity for Pharmaceuticals. (2)
Review activity for Pharmaceutics. (1)
Review activity for Pharmacological Reports. (7)